Navigation Links
JCI table of contents: March 20, 2008
Date:3/20/2008

d whether other genes that are candidates for gene therapy approaches might pose a similar risk. A new study, carried out by Hans-Peter Kiem and colleagues, at the Fred Hutchinson Cancer Research Center, Seattle, has now indicated that early precursors of immune cells that had the gene HOXB4 delivered into them by a gammaretroviral vector became leukemic in 2 of 2 dogs and 1 of 2 macaques. In vitro analysis established a clear link between HOXB4 expression and leukemia, leading the authors to conclude that the use of HOXB4-based gene therapy would probably carry a high risk of leukemia and that extreme caution is needed when considering gene therapy approaches. The need for caution is echoed in an accompany commentary by Andre Larochelle and Cynthia E. Dunbar, at the National Institutes of Health, Bethesda, who discuss how important large animal studies, such as those reported by Hans-Peter Kiem and colleagues, are to minimize the risk of adverse events in humans receiving gene therapy in the future.

TITLE: High incidence of leukemia in large animals after stem cell gene therapy with a HOXB4-expressing retroviral vector

AUTHOR CONTACT:
Hans-Peter Kiem
Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
Phone: (206) 667-4425; Fax: (206) 667-6124; E-mail: hkiem@fhcrc.org.

View the PDF of this article at: https://www.the-jci.org/article.php?id=34371

ACCOMPANYING COMMENTARY

TITLE: HOXB4 and retroviral vectors: adding fuel to the fire

AUTHOR CONTACT:
Cynthia E. Dunbar
National Institutes of Health, Bethesda, Maryland, USA.
Phone: (301) 496-1434; Fax: (301) 496-8396; E-mail: dunbarc@nhlbi.nih.gov.

View the PDF of this article at: https://www.the-jci.org/article.php?id=35326'/>"/>

Contact: Karen Honey
press_releases@the-jci.org
215-573-1850
Journal of Clinical Investigation
Source:Eurekalert

Page: 1 2 3 4 5

Related medicine news :

1. Blue Cross and Blue Shield of Illinois Announces 2007 Charitable Donations
2. GSK Charitable Support Valued at $564 Million in 2007
3. JCI online early table of contents: March 13, 2008
4. Implantable medical devices may expose patients to security, privacy risks; solutions suggested
5. Perrigo Company to Market Over-the-Counter Cetirizine Hydrochloride, Pseudoephedrine Hydrochloride Extended-Release Tablets
6. Perrigo Company Announces Initial Shipments of Store Brand Omeprazole Tablets
7. V8 V-Fusion(R) Takes an Exotic, Tasty Twist on Vegetable Juice
8. JCI online early table of contents: March 3, 2008
9. AXA Equitable Meets the Needs of Two People under One Life Insurance Policy
10. Nanomedicine system engineered to enhance therapeutic effects of injectable drugs
11. Nurses Convince Hospital to Return to Bargaining Table
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/18/2014)... 18, 2014) Benaroya Research Institute at Virginia Mason ... a particular molecule in metastatic breast cancer reduces both ... lung metastases. BRI scientists have found in models of ... by 60 - 80 percent and can keep the ... $1.8 million five-year grant comes from the National Cancer ...
(Date:4/18/2014)... 18, 2014) ― A new study in the ... in health-related Google searches reveals a recurring pattern that ... , Investigators from San Diego State University, the ... Campaigns, analyzed "healthy" Google searches (searches that included the ... originating in the U.S. from 2005 to 2012. They ...
(Date:4/18/2014)... Medicine scientists could lead to potential new treatments for ... scleroderma. , Fibrosis, or scarring, is a hallmark ... and lungs can lead to serious organ damage and, ... therapeutic options centers on findings made by Swati Bhattacharyya, ... role that a specific protein plays in promoting fibrosis. ...
(Date:4/17/2014)... who show signs of chronic inflammation in non-cancerous prostate ... having prostate cancer than those with no inflammation, according ... from the Johns Hopkins Kimmel Cancer Center. , The ... for men with so-called high-grade prostate cancer those ... indicating the presence of the most aggressive and rapidly ...
(Date:4/17/2014)... Scientists have identified new pain relief targets that ... pain. BBSRC-funded researchers at King,s College London made ... nerves in the periphery of the body. , ... and identifying mechanisms underlying pain generation and our ... related side effects." , One potential side effect ...
Breaking Medicine News(10 mins):Health News:Benaroya Research Institute evaluates immunology approach to blocking breast cancer 2Health News:New research shows people are thinking about their health early in the week 2Health News:New clues on tissue scarring in scleroderma 2Health News:Chronic inflammation linked to 'high-grade' prostate cancer 2Health News:Chronic inflammation linked to 'high-grade' prostate cancer 3Health News:New pain relief targets discovered 2
... , DALLAS, Jan. 11 The American ... effort led by the Department of Health and Human Services ... encourage more Americans to get vaccinated against H1N1. ... people with heart failure or with any cardiovascular disease. Like ...
... researchers suggest , MONDAY, Jan. 11 (HealthDay News) -- A ... genetic variant associated with the aggressiveness of prostate cancer, in ... out cancers that need intensive treatment from those that can ... principle to show that there are variants in the genome ...
... ... , ... Primary care physicians may be able to help increase Americans, willingness to become organ donors ... about end-of-life care, according to a study in the January issue of the Journal of ...
... , , BATESVILLE, Ind., Jan. 11 Hillenbrand, Inc. (NYSE: ... to 1:30 p.m. in New York, N.Y., on Jan. 14, 2010, and ... for Hillenbrand to acquire K-Tron International, Inc. ( KTII). , You are ... hear from and meet members of the Hillenbrand and K-Tron management teams ...
... , FAIRVIEW, Pa., Jan. 11 ... and manufacturer of custom electronic products and systems, today reported results ... , For the fourth quarter of fiscal 2009, the Company ... on sales of $34.1 million, compared to net income of $2.5 ...
... Amounts deemed safe are still too high, researchers say , ... of lead may harm children,s kidneys, say U.S. researchers. , ... per deciliter of blood, according to the U.S. Centers for ... Center study suggests that even levels below 10 micrograms are ...
Cached Medicine News:Health News:American Heart Association Encourages Heart Disease Patients to Get H1N1 Flu Shot in Support of National Influenza Vaccination Week, Jan. 10-16 2Health News:Genetic Marker for Aggressive Prostate Cancer Found 2Health News:Genetic Marker for Aggressive Prostate Cancer Found 3Health News:New Study Says Doctors' Offices -- Not the DMV -- Should Be Where Americans Decide to Become Organ Donors 2Health News:New Study Says Doctors' Offices -- Not the DMV -- Should Be Where Americans Decide to Become Organ Donors 3Health News:New Study Says Doctors' Offices -- Not the DMV -- Should Be Where Americans Decide to Become Organ Donors 4Health News:Hillenbrand to Host Investor Luncheons in New York City and Boston 2Health News:Hillenbrand to Host Investor Luncheons in New York City and Boston 3Health News:Hillenbrand to Host Investor Luncheons in New York City and Boston 4Health News:Hillenbrand to Host Investor Luncheons in New York City and Boston 5Health News:Spectrum Control Reports Fourth Quarter and Annual Profit 2Health News:Spectrum Control Reports Fourth Quarter and Annual Profit 3Health News:Spectrum Control Reports Fourth Quarter and Annual Profit 4Health News:Spectrum Control Reports Fourth Quarter and Annual Profit 5Health News:Spectrum Control Reports Fourth Quarter and Annual Profit 6Health News:Spectrum Control Reports Fourth Quarter and Annual Profit 7Health News:Spectrum Control Reports Fourth Quarter and Annual Profit 8Health News:Spectrum Control Reports Fourth Quarter and Annual Profit 9Health News:Very Low Levels of Lead Harm Kids' Kidneys: Study 2
(Date:1/15/2014)... 15, 2014 Massachusetts General Hospital (MGH), the ... ) announced today that they have launched a ... therapeutic targets and develop novel therapies for inflammatory ... millions worldwide. The MGH-Broad-Amgen collaboration brings together scientists ...
(Date:1/15/2014)... 15, 2014  Humberto C. Antunes,  Galderma  worldwide CEO, will ... Journal of Drugs in Dermatology (JDD) at ... The event is January 17-20, 2014, at the Omni Orlando Resort ... The ODAC is a distinguished event that ...
(Date:1/15/2014)... 2014  Manufacturers, suppliers and distributors of innovative medical-related ... their most important business assets, intellectual property (IP). ... Because of the highly-competitive nature of the ... the most litigious industry sectors of cases involving ...
Breaking Medicine Technology:Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 2Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 3Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 4Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 2Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 3Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 4Intellectual Property Insurance for Medical-related Products and Services 2
... following is being released by SafeMinds ( www.SafeMinds.org ): ... has publicly denied a vaccine-autism link, while at the ... been awarding damages for vaccine injury to children with ... on verifiable government data, breaks ground in the controversial ...
... Perrigo Company (Nasdaq: PRGO ; TASE) today ... relating to fluticasone lotion brought by Nycomed US Inc. by ... of the settlement, Perrigo can launch a generic version of ... certain circumstances. Cutivate® (fluticasone) lotion is indicated ...
Cached Medicine Technology:83 Cases of Autism Associated with Childhood Vaccine Injury Compensated in Federal Vaccine Court 2Perrigo Announces Settlement of Cutivate Lotion Litigation 2
ReNu 1 Step Enzymatic Cleaner with ReNu Multi-Purpose Solution removes protein deposits while lenses are being disinfected. Its a one-step process that saves time. Removes stubborn deposits from dai...
...
Wet-Field Hemostatic Eraser bipolar tip, packsize is 10/box....
... intraocular lenses. The instrument consists of a ... implant and divides the implant into two ... halves of the lens so that unwanted ... chamber is avoided. The instrument is passed ...
Medicine Products: